CRH and Lewy body dementia: CRH levels were also reduced in SAA+ CUI (pre-clinical Lewy body disease), in which the presence of αSyn could indicate a higher risk for disease progression.20 This suggests CRH dysregulation might occur early in the disease course, despite the limited pre-clinical sample size.